| Application Number | Priority Date | Filing Date | Title | 
|---|---|---|---|
| GBGB0714129.4AGB0714129D0 (en) | 2007-07-19 | 2007-07-19 | compounds | 
| PCT/EP2008/059387WO2009010560A1 (en) | 2007-07-19 | 2008-07-17 | Pyrazole derivatives and use thereof as inhibitors of stearoyl-coa desaturase | 
| Application Number | Priority Date | Filing Date | Title | 
|---|---|---|---|
| GBGB0714129.4AGB0714129D0 (en) | 2007-07-19 | 2007-07-19 | compounds | 
| Publication Number | Publication Date | 
|---|---|
| GB0714129D0true GB0714129D0 (en) | 2007-08-29 | 
| Application Number | Title | Priority Date | Filing Date | 
|---|---|---|---|
| GBGB0714129.4ACeasedGB0714129D0 (en) | 2007-07-19 | 2007-07-19 | compounds | 
| Country | Link | 
|---|---|
| GB (1) | GB0714129D0 (en) | 
| WO (1) | WO2009010560A1 (en) | 
| Publication number | Priority date | Publication date | Assignee | Title | 
|---|---|---|---|---|
| GB0722077D0 (en) | 2007-11-09 | 2007-12-19 | Smithkline Beecham Corp | Compounds | 
| GB0722075D0 (en) | 2007-11-09 | 2007-12-19 | Smithkline Beecham Corp | Compounds | 
| SG10201502484SA (en) | 2010-03-30 | 2015-05-28 | Verseon Corp | Multisubstituted aromatic compounds as inhibitors of thrombin | 
| MX2014004426A (en) | 2011-10-15 | 2014-07-09 | Genentech Inc | Scd1 antagonists for treating cancer. | 
| SG10201707486XA (en) | 2013-03-15 | 2017-10-30 | Verseon Corp | Halogenopyrazoles as inhibitors of thrombin | 
| EP2968297B1 (en) | 2013-03-15 | 2018-09-26 | Verseon Corporation | Multisubstituted aromatic compounds as serine protease inhibitors | 
| CN106687445A (en) | 2014-09-17 | 2017-05-17 | 维颂公司 | Pyrazolyl-substituted pyridone compounds as serine protease inhibitors | 
| PT3261639T (en) | 2015-02-27 | 2022-11-25 | Verseon Int Corporation | Substituted pyrazole compounds as serine protease inhibitors | 
| JP2019533022A (en) | 2016-10-24 | 2019-11-14 | ユマニティ セラピューティクス,インコーポレーテッド | Compounds and uses thereof | 
| CA3049010A1 (en) | 2017-01-06 | 2018-07-12 | Yumanity Therapeutics, Inc. | Methods for the treatment of neurological disorders | 
| WO2019084157A1 (en) | 2017-10-24 | 2019-05-02 | Yumanity Therapeutics, Inc. | Compounds and uses thereof | 
| MX2020009942A (en) | 2018-03-23 | 2021-01-08 | Yumanity Therapeutics Inc | Compounds and uses thereof. | 
| US12098146B2 (en) | 2019-01-24 | 2024-09-24 | Janssen Pharmaceutica Nv | Compounds and uses thereof | 
| EA202192047A1 (en) | 2019-11-13 | 2021-12-08 | Юманити Терапьютикс, Инк. | COMPOUNDS AND THEIR APPLICATIONS | 
| Publication number | Priority date | Publication date | Assignee | Title | 
|---|---|---|---|---|
| WO2006101521A2 (en)* | 2004-09-20 | 2006-09-28 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors | 
| CA2580845A1 (en)* | 2004-09-20 | 2006-03-30 | Xenon Pharmaceuticals Inc. | Pyridazine derivatives for inhibiting human stearoyl-coa-desaturase | 
| GB0508472D0 (en)* | 2005-04-26 | 2005-06-01 | Glaxo Group Ltd | Compounds | 
| GB0625654D0 (en)* | 2006-12-21 | 2007-01-31 | Smithkline Beecham Corp | Compounds | 
| GB0625604D0 (en)* | 2006-12-21 | 2007-01-31 | Smithkline Beecham Corp | Compounds | 
| GB0625605D0 (en)* | 2006-12-21 | 2007-01-31 | Smithkline Beecham Corp | Compounds | 
| Publication number | Publication date | 
|---|---|
| WO2009010560A1 (en) | 2009-01-22 | 
| Publication | Publication Date | Title | 
|---|---|---|
| GB0706793D0 (en) | Compounds | |
| GB0704407D0 (en) | Compounds | |
| GB0704394D0 (en) | Compounds | |
| GB0714129D0 (en) | compounds | |
| GB0705672D0 (en) | Compounds | |
| GB0706173D0 (en) | Compounds | |
| GB0706168D0 (en) | Compounds | |
| GB0707034D0 (en) | Compounds | |
| GB0707092D0 (en) | Compounds | |
| GB0706188D0 (en) | Compounds | |
| GB0706165D0 (en) | Compounds | |
| GB0706167D0 (en) | Compounds | |
| GB0706174D0 (en) | Compounds | |
| GB0706187D0 (en) | Compounds | |
| GB0706189D0 (en) | Compounds | |
| GB0706164D0 (en) | Compounds | |
| GB0706170D0 (en) | Compounds | |
| GB0706190D0 (en) | Compounds | |
| GB0704939D0 (en) | Compounds | |
| GB0703756D0 (en) | Compounds | |
| GB0701985D0 (en) | Compounds | |
| GB0701955D0 (en) | Compounds | |
| GB0700112D0 (en) | Compounds | |
| GB0702973D0 (en) | Compounds | |
| GB0705330D0 (en) | Compounds | 
| Date | Code | Title | Description | 
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |